A new drug that revolutionizes the treatment of Alzheimer’s disease

0
56


Scientists have reached it at Temple University School of Medicine in Pennsylvania

The Sun newspaper: A number of American scientists have devised the first drug to prevent Alzheimer’s disease, which promotes a chemical “cleansing” the brain of proteins that cause memory loss and confusion.

According to the newspaper, research on modified mice to develop age-related disease showed that rodents showed no symptoms after injecting them into the compound.

The research team from Temple University School of Medicine in Pennsylvania said that the results shed light on Alzheimer’s disease, which raises hope that the drug may slow or even reflect dementia in humans.

People with Alzheimer’s suffer from a decrease in cognitive, behavioral, and physical abilities, and so far there are no treatments that can correct this, because current treatments only help relieve symptoms.

This new drug potentially revolutionizing Alzheimer’s disease is known as pharmacological chaperone, which corrects mutations in amyloid beta and tau proteins that collect in patients ’brains forming plaques that result in a loss of connections between neurons in the brain, and ultimately the death of those cells and tissue loss The brain.

The team is now planning clinical trials of the drug in humans, and they first do not want to check its effects on older mice who already have Alzheimer’s.

Alzheimer’s disease
chemical substance

A new drug that revolutionizes the treatment of Alzheimer’s disease

Already

The Sun newspaper: A number of American scientists have devised the first drug to prevent Alzheimer’s disease, which promotes a chemical “cleansing” the brain of proteins that cause memory loss and confusion.

According to the newspaper, research on modified mice to develop age-related disease showed that rodents showed no symptoms after injecting them into the compound.

The research team from Temple University School of Medicine in Pennsylvania said that the results shed light on Alzheimer’s disease, which raises hope that the drug may slow or even reflect dementia in humans.

People with Alzheimer’s suffer from a decrease in cognitive, behavioral, and physical abilities, and so far there are no treatments that can correct this, because current treatments only help relieve symptoms.

This new drug potentially revolutionizing Alzheimer’s disease is known as pharmacological chaperone, which corrects mutations in amyloid beta and tau proteins that collect in patients ’brains forming plaques that result in a loss of connections between neurons in the brain, and ultimately the death of those cells and tissue loss The brain.

The team is now planning clinical trials of the drug in humans, and they first do not want to check its effects on older mice who already have Alzheimer’s.

January 23, 2020 – Jun 28, 1441

08:46 AM


Scientists have reached it at Temple University School of Medicine in Pennsylvania

The Sun newspaper: A number of American scientists have devised the first drug to prevent Alzheimer’s disease, which promotes a chemical “cleansing” the brain of proteins that cause memory loss and confusion.

According to the newspaper, research on modified mice to develop age-related disease showed that rodents showed no symptoms after injecting them into the compound.

The research team from Temple University School of Medicine in Pennsylvania said that the results shed light on Alzheimer’s disease, which raises hope that the drug may slow or even reflect dementia in humans.

People with Alzheimer’s suffer from a decrease in cognitive, behavioral, and physical abilities, and so far there are no treatments that can correct this, because current treatments only help relieve symptoms.

This new drug potentially revolutionizing Alzheimer’s disease is known as pharmacological chaperone, which corrects mutations in amyloid beta and tau proteins that collect in patients ’brains forming plaques that result in a loss of connections between neurons in the brain, and ultimately the death of those cells and tissue loss The brain.

The team is now planning clinical trials of the drug in humans, and they first do not want to check its effects on older mice who already have Alzheimer’s.

LEAVE A REPLY

Please enter your comment!
Please enter your name here